Literature DB >> 2608597

Neuroleptic malignant syndrome: another medical cause of acute abdomen.

T C Lo1, M R Unwin, I W Dymock.   

Abstract

We present a patient with neuroleptic malignant syndrome and intestinal pseudo-obstruction misdiagnosed as being secondary to septicaemia. The management of the patient is discussed with emphasis on the role of creatine kinase and liver function tests.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2608597      PMCID： PMC2429179          DOI： 10.1136/pgmj.65.767.653

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  14 in total

1.  Creatine kinase isoenzyme patterns in human tissue obtained at surgery.

Authors:  S H Tsung
Journal:  Clin Chem       Date:  1976-02       Impact factor: 8.327

2.  Pseudo-obstruction.

Authors:  H A Dudley; S Paterson-Brown
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-03

Review 3.  Creatine kinase isoenzymes in the assessment of heart disease.

Authors:  R Roberts; B E Sobel
Journal:  Am Heart J       Date:  1978-04       Impact factor: 4.749

4.  Neuroleptic malignant syndrome: review and analysis of 115 cases.

Authors:  G Addonizio; V L Susman; S D Roth
Journal:  Biol Psychiatry       Date:  1987-08       Impact factor: 13.382

5.  Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'.

Authors:  D F Levinson; G M Simpson
Journal:  Arch Gen Psychiatry       Date:  1986-09

Review 6.  The neuroleptic malignant syndrome--a review.

Authors:  W R Gibb; A J Lees
Journal:  Q J Med       Date:  1985-08

7.  Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.

Authors:  H H Harsch
Journal:  J Clin Psychiatry       Date:  1987-08       Impact factor: 4.384

Review 8.  Neuroleptic malignant syndrome.

Authors:  R J Abbott; L A Loizou
Journal:  Br J Psychiatry       Date:  1986-01       Impact factor: 9.319

9.  Bromocriptine treatment of neuroleptic malignant syndrome.

Authors:  S Dhib-Jalbut; R Hesselbrock; M M Mouradian; E D Means
Journal:  J Clin Psychiatry       Date:  1987-02       Impact factor: 4.384

Review 10.  The neuroleptic malignant syndrome: agent and host interaction.

Authors:  A Shalev; H Munitz
Journal:  Acta Psychiatr Scand       Date:  1986-04       Impact factor: 6.392
View more
  1 in total

Review 1.  Pain management in neurocritical care.

Authors:  Axel Petzold; Armand Girbes
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.